147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
More posts

Hla-class ii artificial antigen presenting cells in cd4 + t cell-based

CD4 T cell help is essential to promote robust cytotoxic T cell responses and could be harnessed to improve outcomes of cancer immunotherapy. To […]

Method and apparatus for acquiring a spatial map of auditory

This method for acquiring a spatial map of auditory perception of a subject comprises a plurality of successive test sequences, each test sequence […]

Ctip fusion to cas9 enhances transgene integration by

The present invention relates to nuclease protein fusions for enhancing genome editing by homology-directed transgene integration (HDI).rnrnThe […]

Methods and kits for detecting protein-protein interactions

The present invention relates to methods and kits for detection protein-protein interactions.rnrnIn particular, the present invention relates to a […]

Crispr barcoding: method and kit for labeling and detecting a

The invention relates to methods, compositions and kits for labelling and detecting endonuclease-treated cells, and most preferably eukaryotic […]

Methods and compositions for the preservation of organs

The present invention relates to methods and compositions for the preservation of organs.rnrnIn particular, the present invention relates to an […]

Method for universal detection and quantification of mycoplasma

The present invention relates to a method for detecting mycoplasma 16S rDNA 1.5 kilobase fragment amplified quantitative polymerase chain reaction […]

Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of LRRC33 by Sézary cells. LRRC33 therefore […]

Garp as a biomarker and biotarget in t-cell malignancies

The present study of the regulatory T phenotype of Sézary cells led to the discovery of the expression of GARP (LRRC32) by Sézary cells. GARP has […]

Methods for the diagnosis and treatment of acute lymphoblastic

The present invention relates to a method of treating acute lymphoblastic leukemia in a patient in need thereof comprising administering to the […]

More posts

You might also be interested in